GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA

GE HealthCare today announced that StarGuide GX,i its new digital 4D CZT SPECT/CT technology, is 510(k) pending with the U.S.
Zacks Investment Research on MSN

GE HealthCare moves StarGuide GX 4D SPECT/CT toward FDA clearance

GE HealthCare Technologies Inc. GEHC recently announced that it is taking its next-generation StarGuide GX digital 4D cadmium ...
The Globe and Mail

GE Healthcare’s New SPECT/CT Trial Signals Next Wave of Imaging Growth for GEHC

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities ...
The Financial

GE Healthcare Introduces Performance SPECT/CT System

The FINANCIAL — At the Society of Nuclear Medicine this year, GE Healthcare is introducing the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT system—the Optima ...
Nasdaq

GE Healthcare Announces First Patient Dosed in Phase III Clinical Trial for New Dopamine Transporter Imaging Radiopharmaceutical

First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation ...
Nasdaq

GEHC Stock May Gain Following the Launches of Aurora and Clarify DL

GE HealthCare Technologies Inc. GEHC recently unveiled Aurora, a new dual-head single-photon emission computed tomography/ computed tomography (SPECT/CT) designed to help clinicians visualize better ...
MarketScreener

GE HealthCare Announces StarGuide GX 4D SPECT/CT 510(k) Pending With U.S. FDA

GE HealthCare had announced that StarGuide GX,i its new digital 4D CZT SPECT/CT technology, is 510(k) pending with the U.S. Food and Drug Administration (FDA). Building on the system?s recent CE Mark, ...